Maynard Um
-
-
-
-
-
-
-
NextCure delays LNCB74 trial data, expects SIM0505 results in Q2 2026
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on NextCure Inc. (NXTC)
-
-
-
-
-
-
-
NextCure, Inc. (NXTC) Misses Q2 EPS by 17c
431,455 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

